However, Trip10 overexpression enhances pancreatic cancer cell migration by downregulating the antitumor function of ArgBP2, suggesting that Trip10 contributes to the malignancy of pancreatic cancer [11]. This evidence concerns the gene SORBS2 and familial pancreatic carcinoma.